Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials.

Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials.

AIM:We assessed the efficacy and safety of 5-hydroxytryptamine (5-HT3) receptor antagonists in adults with non-constipated irritable bowel syndrome (IBS) or diarrhea-predominant IBS (IBS-D). METHODS:We searched PubMed, MEDLINE, EMBASE, and the Cochrane Controlled Trials Register for randomized contr...

Full description

Bibliographic Details
Main Authors:	Yongping Zheng, Ting Yu, Yurong Tang, Wenjie Xiong, Xiaoxue Shen, Ling Jiang, Lin Lin
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5349445?pdf=render

Similar Items

Efficacy and Safety of Antidepressants for the Treatment of Irritable Bowel Syndrome: A Meta-Analysis.
by: Chen Xie, et al.
Published: (2015-01-01)

Clinical efficacy of 5-hydroxytryptamine 3 receptor antagonists in reducing propofol injection pain, postoperative nausea/vomiting and shivering: A meta-analysis
by: Zhou Wenjie, et al.
Published: (2020-03-01)

Research Progress of Traditional Chinese and Western Medicine in the Treatment of Irritable Bowel Syndrome Based on 5-hydroxytryptamine
by: Pengning WU, Shuai XIONG, Xiaohan JIANG, Yi ZHANG, Chao LIANG, Min CHEN
Published: (2022-05-01)

Association of 5-Hydroxytryptamine 3 Receptor Antagonists With the Prognosis of Liver Failure
by: Yuting Chen, et al.
Published: (2021-04-01)

Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis
by: Jian-Rong Sun, et al.
Published: (2020-01-01)

Efficacy and Safety of Probiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
by: Bing Li, et al.
Published: (2020-04-01)

The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting
by: Palli SR, et al.
Published: (2015-06-01)

Review article: the therapeutic potential of 5-HT3 receptor antagonists in the treatment of irritable bowel syndrome.
by: Humphrey, P, et al.
Published: (1999)

Efficacy and Safety of Probiotics, Prebiotics and Synbiotics in the Treatment of Irritable Bowel Syndrome: A systematic review and meta-analysis
by: Mohammad Z. Asha, et al.
Published: (2020-03-01)

Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist
by: Toru Arai, et al.
Published: (2022-09-01)

5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia
by: Ivan V. Pozhidaev, et al.
Published: (2020-04-01)

Efficacy of Peppermint Oil in Irritable Bowel Syndrome
by: Suhasini Dehury, et al.
Published: (2022-06-01)

Efficacy and safety of fecal microbiota transplant in irritable bowel syndrome: An update based on meta‐analysis of randomized control trials
by: Yomna Ali Abdelghafar, et al.
Published: (2022-09-01)

Long-term efficacy and safety of ramosetron in the treatment of diarrhea-predominant irritable bowel syndrome
by: Chiba T, et al.
Published: (2013-07-01)

Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis
by: Tao Zhang, et al.
Published: (2022-04-01)

Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome
by: Lin Xiao, et al.
Published: (2021-09-01)

Ethanol Extract of Mao Jian Green Tea Attenuates Gastrointestinal Symptoms in a Rat Model of Irritable Bowel Syndrome with Constipation via the 5-hydroxytryptamine Signaling Pathway
by: Lei Wu, et al.
Published: (2023-03-01)

Epigenetic Mechanisms in Irritable Bowel Syndrome
by: Swapna Mahurkar-Joshi, et al.
Published: (2020-08-01)

Serotonin receptor modulators in the treatment of irritable bowel syndrome
by: Mohammad Fayyaz, et al.
Published: (2008-03-01)

Efficacy of probiotic adjuvant therapy for irritable bowel syndrome in children: A systematic review and meta-analysis.
by: Hua-Lan Xu, et al.
Published: (2021-01-01)

Efficacy of Kolofort for the treatment of patients with irritable bowel syndrome
by: V V Tsukanov, et al.
Published: (2016-08-01)

Efficacy and safety of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists in augmentation with selective serotonin reuptake inhibitors (SSRIs) in the treatment of moderate to severe obsessive–compulsive disorder: a systematic review and meta-analysis of randomized clinical trials
by: Negin Eissazade, et al.
Published: (2023-11-01)

Comparison of netupitant/palonosetron with 5-hydroxytryptamine-3 receptor antagonist in preventing of chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation
by: Hang Zhang, et al.
Published: (2023-11-01)

Efficacy of different courses of acupuncture for diarrhea irritable bowel syndrome: A protocol for systematic review and meta-analysis
by: Junjian Tian, et al.
Published: (2023-01-01)

5-Hydroxytryptamine and punishment.
by: Tye, N, et al.
Published: (1977)

The efficacy of vitamin D supplementation for irritable bowel syndrome: a systematic review with meta-analysis
by: Hangkai Huang, et al.
Published: (2022-05-01)

Efficacy of pinaverium bromide in the treatment of irritable bowel syndrome: a systematic review and meta-analysis
by: Serhat Bor, et al.
Published: (2021-09-01)

Efficacy and safety of Modified Tongxie Yaofang in diarrhea-predominant irritable bowel syndrome management: A meta-analysis of randomized, positive medicine-controlled trials.
by: Yun-Kai Dai, et al.
Published: (2018-01-01)

Defining the irritable bowel
by: Kee Huat Chuah, et al.
Published: (2022-04-01)

The irritable bowel syndrome
by: Vaerenbergh Wim, et al.
Published: (1998-01-01)

Irritable Bowel Syndrome
by: Jae Hak Kim, et al.
Published: (2019-02-01)

Irritable bowel syndrome
by: Vasile Valeriu LUPU, et al.
Published: (2016-03-01)

Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine
by: Mauro Bafutto, et al.
Published: (2011-03-01)

Efficacy of the Rome criteria II in diagnosis of irritable bowel syndrome
by: A I Parfenov, et al.
Published: (2004-04-01)

Irritable brain caused by irritable bowel? A nationwide analysis for irritable bowel syndrome and risk of bipolar disorder.
by: Chia-Jen Liu, et al.
Published: (2015-01-01)

Efficacy and safety of fecal microbiota transplantation for the treatment of irritable bowel syndrome: an overview of overlapping systematic reviews
by: Di Zhang, et al.
Published: (2023-10-01)

Long-term efficacy and safety of otilonium bromide in the management of irritable bowel syndrome: a literature review
by: Triantafillidis JK, et al.
Published: (2014-04-01)

Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis
by: Peiwei Xie, et al.
Published: (2023-09-01)

Efficacy of a Restrictive Diet in Irritable Bowel Syndrome: A Systematic Review and Network Meta-analysis
by: Seung Jung Yu, et al.
Published: (2022-07-01)

The efficacy and neural mechanism of acupuncture therapy in the treatment of visceral hypersensitivity in irritable bowel syndrome
by: Yuanzhen Yang, et al.
Published: (2023-09-01)